Webinar Summary
- The importance of stable cell line development in large-scale antibody production
- Overcoming key challenges in the development process
- Choosing the right approach and partners for this critical phase
- How a seamless partnership between CROs and CDMOs streamlines the path to GMP compliance
Don't miss this opportunity to lay the groundwork for a successful CLD project and make informed decisions that will drive your project's success!
Stable cell line development is a critical step in creating new biopharmaceuticals and immunodiagnostics. Achieving stable and durable expression, high clonal homogeneity, and strong yield can profoundly impact the success of downstream development. However, numerous challenges make this process both complex and high-risk.
In this webinar, experts from ProteoGenix (CRO) and Eurofins (CMO) discuss the key challenges in stable cell line development and share actionable strategies to overcome them. Learn how to select a trusted partner and discover why close collaboration between a CRO specialized in stable cell lines and a CMO ensures a seamless transition to GMP manufacturing success.
Presenters
Laura Radu
Laura leads the Account Management team in the Recombinant Protein and Antibody Production Department at ProteoGenix. With a Ph.D. in Molecular Biophysics, she has completed postdoctoral research at IGBMC in Strasbourg and the University of Cambridge.
Her expertise lies in recombinant antibody production, stable cell line development, and managing complex scientific projects. Laura combines her deep understanding of molecular biology, protein biochemistry, and structural biology with over five years of industry experience to deliver tailored biotech solutions.
Jo Vercammen
Jo serves as the Senior Director of Business Development at Eurofins CDMO, where he leads the sales and technical team. With a Ph.D. in Biophysical Biochemistry from the University of Leuven in Belgium, Jo has a robust background as a biochemist. He dedicated over six years to Ablynx, managing teams in both the Discovery and CMC groups. For more than 12 years, Jo has been at Eurofins, overseeing various teams in analytics, formulation, and sales. His extensive experience in the pharma sector has involved numerous projects, and he is committed to finding innovative solutions to support clients in the early phases of clinical development.
Sponsor
ProteoGenix
Content Partners
Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.
